L. Navarro

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

A. Belenguer, S. Gil-Perotín, B. Casanova, 2022, Journal of Neurology.

New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

X. Montalban, F. Paul, D. Galimberti, 2020, Frontiers in Neurology.

Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis

X. Montalban, J. Clarimón, A. Lleó, 2018, Multiple sclerosis.

Pulsed steroids followed by glatiramer acetate to prevent inflammatory activity after cessation of natalizumab therapy: a prospective, 6-month observational study

B. Casanova, I. Boscá, M. Simó, 2011, Journal of Neurology.